FibroScan®
White Paper | 17.04.2026
Blog and news
topic :
category :
status :
Webinar | 13.04.2026
Multidisciplinary management of MASLD–MASH: bridging diabetology and hepatology
Webinar | 07.04.2026
FibroScan® Guided VCTE®: Best Practice Review and Clinical Insights
Article | 06.11.2025
Statement on the acceptance by the FDA of Echosens’ Letter of Intent for Drug Development Tool (DDT)
Article | 16.09.2025
A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH
Webinar | 26.08.2025
Beyond the Numbers: FibroScan® Insights for MASLD Management
Press Release | 18.08.2025
Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH
Press Release | 15.07.2025
Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics
Press Release | 10.06.2025
Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care
Article | 10.06.2025
A call for doubling the diagnostic rate of at-risk MASH
Congress | 24.04.2025
Echosens is at EASL
Webinar | 14.04.2025
Management of liver health in people at metabolic risk
Article | 13.03.2025
New publication on our new technology Guided VCTE™
Webinar | 04.12.2024
Identification & Management of MASLD in APAC
Press Release | 22.11.2024